Mkts

Cytosorbents Corporation

NASDAQ: CTSO
$5.27-0.74 (-12.31%)
As of Oct 23, 4:00 PM ET

Key statistics

Day range
5.225.96
52-week range
2.8417.28
Today
Open5.90
Previous close5.27
Volume—
Valuation
Market cap16.61M
P/E ratio—
EPS (TTM)-0.29
Income & risk
Dividend / yield—
Beta1.47
Avg volume23.7K
Discussion

CTSO News

Stories mentioning CTSO from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold2,7342,4302,8192,8032,5202,8963,3572,339
Gross Profit6,1306,8046,6666,8146,2076,2545,2566,503
Operating Expenses
Research & Development1,0251,6631,8511,520
Sales General & Admin8,1499,4368,6109,1678,4327,6358,2608,554
Total Operating Expenses9,17411,1889,52810,42910,0959,65010,08610,073
Operating Income (Loss)(3,044)(4,384)(2,862)(3,615)(3,888)(3,396)(4,830)(3,570)
Interest Income
Interest Expense
Other Expense
Pretax Income(3,571)(1,478)(9,410)(2,768)(4,143)
Tax Provision0.00(401.00)0.000.00
Net Income (Loss)(5,129)(5,496)(3,170)1,947(1,479)(7,568)(2,768)(4,294)
Earnings Per Share (Basic)(0.08)(0.09)(0.05)0.03(0.02)(0.14)(0.05)(0.08)
Earnings Per Share (Diluted)(0.08)(0.09)(0.05)0.03(0.02)(0.14)(0.05)(0.08)
Weighted Average Shares Outstanding (Basic)62,73962,23262,75462,60960,73254,43554,45354,306
Weighted Average Shares Outstanding (Diluted)62,73962,23262,75467,16660,73254,43554,45354,306

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CTSO

Cytosorbents Corporation (NASDAQ: CTSO) is a stock listed on the Nasdaq Stock Market under the ticker symbol CTSO. It last traded at $5.27 (Oct 23, 2026, 4:00 PM ET), down 12.3% on the day. That gives Cytosorbents a market capitalisation of $16.6M.

Over the past 52 weeks CTSO has traded between $2.84 and $17.28.

For the quarter ended Mar 31, 2026 it reported a net loss of $5.1M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$5.1M
Dec 31, 2025—-$5.5M
Sep 30, 2025—-$3.2M
Jun 30, 2025—$1.9M

From Cytosorbents’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…